Turbine Announces Collaboration to Uncover Biological Mechanisms of Drug Resistance in Hematological Cancers

Contributed by: Business Wire

Logo

Tags

Biotechnology

Health

Genetics

Pharmaceutical

Oncology

Collaboration with AstraZeneca

More Like This

Turbine Establishes Research Collaboration with Ono Pharmaceutical to Identify and Validate Novel Oncology Targets

Turbine Achieves Key Milestone in Collaboration with Ono Pharmaceutical

Turbine Announces New Appointments to its Board of Directors

Turbine Launches the World’s First Virtual Lab Using Cell Simulations

Turbine and Harmonic Discovery Pair Simulation-Guided Biology and Multi-Target Kinase Inhibition Chemistry Expertise to Develop a Novel Cancer Therapy

BenevolentAI and AstraZeneca Collaboration Yields Continued Success as Further Novel Target Progressed Into Portfolio

Business Wire embedded0

Thermo Fisher Scientific Announces R&D Partnership with AstraZeneca BioVentureHub

BenevolentAI Announces Further Success With AstraZeneca Collaboration as Novel Heart Failure Target Selected